Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 3,5 Dichlorobenzyl Alcohol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115819186B reveals a safer Borane-THF reduction route for 3,5-dichlorobenzyl alcohol, eliminating genotoxic impurities and reducing manufacturing costs for pharmaceutical intermediates.
Solve impurity E risks & cost issues in 3,5-dichlorobenzyl alcohol production. New method ensures >99.9% purity, 96% yield, and eliminates warning structure impurities for pharma supply chains.